Navigation Links
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
Date:11/6/2008

ember 31, 2007

(dollars in thousands)

Cash, cash equivalents and investments (c) $432,833 $603,840

Total assets (c) 747,408 949,105

Total debt and lease financing 755,908 754,099

Total stockholders' equity (deficit) (198,980) (11,902)

(c) Includes $72,562 and $70,931 in restricted investments at September 30, 2008 and December 31, 2007, respectively.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
2. Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
3. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
4. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
5. Human Pheromone Sciences, Inc. - Shareholder Update
6. The human brain minimizes energy expenditure and integrates gravity in to the action plan
7. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
8. Humanitarian Offers $75 Million for Single Dose Sterilization of Cats and Dogs
9. Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
10. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
Post Your Comments:
*Name:
*Comment:
*Email: